{"transactions":[{"id":2749705,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-14T20:19:55.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":5000,"price":45,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":179833,"source":{"system":"sec-edgar","filing":"0001179110-21-004416","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021004416/edgar.xml","form_type":"4"}},{"id":2826960,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T01:08:14.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":500,"price":46.084,"value":23042.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $45.91 to $46.35. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":184833,"source":{"system":"sec-edgar","filing":"0001179110-21-002487","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021002487/edgar.xml","form_type":"4"}},{"id":2826959,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-02T01:08:14.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":4500,"price":45.2612,"value":203675.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $44.90 to $45.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":185333,"source":{"system":"sec-edgar","filing":"0001179110-21-002487","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021002487/edgar.xml","form_type":"4"}},{"id":2888935,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T23:56:10.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":246,"price":48.6887,"value":11977.4202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $48.65 to $48.77. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":189833,"source":{"system":"sec-edgar","filing":"0001179110-21-001008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001008/edgar.xml","form_type":"4"}},{"id":2888934,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-01T23:56:10.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":4754,"price":48.0893,"value":228616.5322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $47.64 to $48.62. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":190079,"source":{"system":"sec-edgar","filing":"0001179110-21-001008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021001008/edgar.xml","form_type":"4"}},{"id":2925948,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T22:07:07.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":290,"price":43.384,"value":12581.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $43.325 to $43.42. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":194833,"source":{"system":"sec-edgar","filing":"0001179110-21-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021000059/edgar.xml","form_type":"4"}},{"id":2925947,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-04T22:07:07.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":4710,"price":42.882,"value":201974.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $42.33 to $43.305. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":195123,"source":{"system":"sec-edgar","filing":"0001179110-21-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911021000059/edgar.xml","form_type":"4"}},{"id":2955393,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-07T23:05:53.000Z","date":"2020-12-07","kind":"sale","acquired":false,"shares":35086,"price":41,"value":1438526.0,"ownership":{"direct":true},"balance_after":199833,"source":{"system":"sec-edgar","filing":"0001179110-20-011734","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020011734/edgar.xml","form_type":"4"}},{"id":2961119,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T22:55:09.000Z","date":"2020-12-02","kind":"sale","acquired":false,"shares":31792,"price":41,"value":1303472.0,"ownership":{"direct":true},"balance_after":234919,"source":{"system":"sec-edgar","filing":"0001179110-20-011550","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020011550/edgar.xml","form_type":"4"}},{"id":2965309,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-27T22:43:28.000Z","date":"2020-11-27","kind":"sale","acquired":false,"shares":10000,"price":41.25,"value":412500.0,"ownership":{"direct":true},"balance_after":266711,"source":{"system":"sec-edgar","filing":"0001179110-20-011448","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020011448/edgar.xml","form_type":"4"}},{"id":2965308,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-27T22:43:28.000Z","date":"2020-11-25","kind":"sale","acquired":false,"shares":9671,"price":41.5004,"value":401350.3684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average sales price per share. These shares were sold at prices ranging from $41.50 to $41.5102. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":276711,"source":{"system":"sec-edgar","filing":"0001179110-20-011448","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020011448/edgar.xml","form_type":"4"}},{"id":3165559,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-01T23:12:55.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":286382,"source":{"system":"sec-edgar","filing":"0001179110-20-005379","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020005379/edgar.xml","form_type":"4"}},{"id":3200937,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T23:28:41.000Z","date":"2020-03-19","kind":"purchase","acquired":true,"shares":17543,"price":14.2382,"value":249780.7426,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average purchase price per share.  These shares were purchased at prices ranging from $14.15 to $14.25.  The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range."}],"balance_after":277553,"source":{"system":"sec-edgar","filing":"0001179110-20-003999","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/edgar.xml","form_type":"4"}},{"id":3200936,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T23:28:41.000Z","date":"2020-03-19","kind":"purchase","acquired":true,"shares":17543,"price":14.2497,"value":249982.4871,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average purchase price per share.  These shares were purchased at prices ranging from $14.23 to $14.25.  The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range."}],"balance_after":260010,"source":{"system":"sec-edgar","filing":"0001179110-20-003999","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/edgar.xml","form_type":"4"}},{"id":3200935,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-19T23:28:41.000Z","date":"2020-03-19","kind":"purchase","acquired":true,"shares":17543,"price":14.1899,"value":248933.4157,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a weighted average purchase price per share.  These shares were purchased at prices ranging from $14.11 to $14.24.  The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range."}],"balance_after":242467,"source":{"system":"sec-edgar","filing":"0001179110-20-003999","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/edgar.xml","form_type":"4"}},{"id":3540219,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-03T20:17:45.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":12173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2020 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":224924,"source":{"system":"sec-edgar","filing":"0001179110-19-005506","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911019005506/edgar.xml","form_type":"4"}},{"id":3949890,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-02T23:41:27.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":10363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 2, 2019 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":212751,"source":{"system":"sec-edgar","filing":"0001179110-18-006089","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911018006089/edgar.xml","form_type":"4"}},{"id":4331841,"issuer":{"id":793,"kind":"organization","name":"HALOZYME THERAPEUTICS, INC.","symbol":"HALO"},"owners":[{"id":140283,"kind":"person","name":"Kelley Kenneth J","position":1,"cik":"0001291219","reported_name":"Kelley Kenneth J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-05T20:56:59.000Z","date":"2017-05-04","kind":"grant","acquired":true,"shares":14135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) May 4, 2018 or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":202388,"source":{"system":"sec-edgar","filing":"0001179110-17-006699","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1159036/000117911017006699/edgar.xml","form_type":"4"}}]}